Maja Hellfritzsch, Thomas Kümler, Anette Tarp Hansen, Mariann Tang, Kasper Gymoese Berthelsen, Annette Dam Fialla, Anita Sylvest Andersen, Peter Kampmann & Anne-Mette Hvas
Ugeskr Læger 2020;182:V05200309
The importance of venous thromboembolism (VTE) as a major complication in patients with severe corona virus disease 2019 (COVID-19) is becoming increasingly evident. In this review, we describe the proposed pathophysiology of the prothrombotic coagulation changes observed in patients with COVID-19. Further, based on a review of the currently available evidence on VTE prevalence in patients with COVID-19, we present and discuss the recommendations from the Danish Society of Thrombosis and Haemostasis on the use of thromboprophylaxis in patients with COVID-19.